Curanex Pharmaceuticals Inc
CURX
$4.02
$0.020.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 198.90K | 148.90K | 244.30K | 74.40K | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 6.30K | 1.20K | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 490.80K | 367.90K | 327.10K | -- | |
| Total Current Assets | 696.10K | 517.90K | 571.40K | -- | |
|
|
|||||
| Total Current Assets | 696.10K | 517.90K | 571.40K | -- | |
| Net Property, Plant & Equipment | 90.90K | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | 74.70K | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | 0.00 | -- | |
| Total Assets | 786.90K | 517.90K | 646.10K | -- | |
|
|
|||||
| Total Accounts Payable | 126.10K | 5.00K | -- | -- | |
| Total Accrued Expenses | 3.90K | 9.60K | 5.60K | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 62.60K | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 192.60K | 14.60K | 5.60K | -- | |
|
|
|||||
| Total Current Liabilities | 192.60K | 14.60K | 5.60K | -- | |
| Long-Term Debt | 200.00K | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 28.60K | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 421.20K | 14.60K | 5.60K | -- | |
|
|
|||||
| Common Stock & APIC | 925.70K | 925.70K | 925.70K | -- | |
| Retained Earnings | -760.00K | -622.40K | -485.30K | -- | |
| Treasury Stock & Other | 200.00K | 200.00K | 200.00K | -- | |
| Total Common Equity | 365.70K | 503.30K | 640.40K | 60.10K | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | 100.00 | 100.00 | 100.00 | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 100.00 | 100.00 | 100.00 | -- | |
|
|
|||||
| Total Common Equity | 365.70K | 503.30K | 640.40K | 60.10K | |
| Total Preferred Equity | 100.00 | 100.00 | 100.00 | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 365.80K | 503.40K | 640.50K | 60.10K | |
|
|
|||||